By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Development and commercialization of innovative products to enhance cancer care44.81M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States228.37M100.00%